Carr Douglas 4

What Happened
Carr Douglas, SVP Finance & Operations at Century Therapeutics (IPSC), reported a sale of 323 shares on 2026-02-03. The shares were sold at $1.82 each for a total proceeds of approximately $589. The filing indicates these sales were to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-02-03; filing date: 2026-02-05 (appears timely).
• Sale details: 323 shares sold at $1.82 per share; total ≈ $589.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: The sale was automatic to cover tax withholding on RSU vesting (not at the insider’s discretion).
• Transaction code: Reported as a sale (S) with tax-withholding footnote.

Context
This was a small, routine sale to cover tax withholding from RSU vesting rather than an open-market decision to reduce exposure. Such automatic withholding sales are common and generally not taken as a directional signal about the insider’s view of the company.